Skip to main content
Ralph L. Sacco on Muck Rack

Ralph L. Sacco

As seen in: The Washington Post, The Hill, Healio, Healio Neurology, Neurology, Brain & Life, NeurologyLive, Project Manager Today
Lawyer at Cardinal Health Inc.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ralph L.

Contact Ralph L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Renowned neurologist Ralph L. Sacco remembered for leadership, advancements in stroke

|
By Robert Herpen Verified, Heather Biele Verified, Ralph L. Sacco
| Healio Neurology Verified
January 20, 2023 2 min read Renowned neurologist Ralph L. Sacco remembered for leadership, advancements in stroke ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Ralph L.
Open in Who Shared Issue with article?

What Is Considered Normal Blood Pressure?

|
By Ralph L. Sacco
| Brain & Life Verified
Ralph L. Sacco, MD, FAAN, responds: A healthy blood pressure is crucial to reducing the risk of stroke and other cardiovascular diseases. The 2017 guideline from the American Heart Association and the American College of Cardiology says a normal blood pressure reading is anything lower than 130 over 80. How quickly it should be brought down depends on how high it is and how long it's been high.
Open in Who Shared Issue with article?

Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial

|
By Ralph L. Sacco, J. Donald Easton, Maria Cecilia Bahit, Juliane Meyerhoff
| AHA/ASA Journals
Originally published15 Oct 2021https://doi.org/10.1161/CIRCULATIONAHA.121.055176Circulation. 2021;0 Abstract Background: A proportion of patients with embolic stroke of undetermined source (ESUS) have silent atrial fibrillation (AF) or develop AF after the initial evaluation. Better understanding of risk for development of AF is critical to implement optimal monitoring strategies with the goal of preventing recurrent stroke due to underlying AF.
Open in Who Shared Issue with article?
See all 26 licensed articles (30 Total)